Adoptive transfer of cytotoxic T-cells for treatment of residual disease after irradiation

References

• Ahmadzadeh M, Rosenberg S A. TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells. Journal of Immunology 2005; 174: 5215–5223
   PubMed Web of Science ®Google Scholar
• Baumann M, Dubois W, Suit H D. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: Relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units. Radiation Research 1990; 123: 325–330
   PubMed Web of Science ®Google Scholar
• Berinstein N. Overview of therapeutic vaccination approaches for cancer. Semininars in Oncology 2003; 30(Suppl. 8)1–8
   PubMedGoogle Scholar
• Blankenstein T, Qin Z. The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis. Current Opinion in Immunology 2003; 15: 148–154
   PubMed Web of Science ®Google Scholar
• Blankenstein T. The role of tumor stroma in the interaction between tumor and immune system. Current Opinion in Immunology 2005; 17: 180–186
   PubMed Web of Science ®Google Scholar
• Chakraborty M, Abrams S I, Camphausen K, Liu K, Scott T, Coleman C N, Hodge J W. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. Journal of Immunology 2003; 170: 6338–6347
   PubMed Web of Science ®Google Scholar
• Chakravarty P K, Alfieri A, Thomas E K, Beri V, Tanaka K E, Vikram B, Guha C. Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Research 1999; 59: 6028–6032
   PubMed Web of Science ®Google Scholar
• Chang C C, Ferrone S. Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunolology and Immunotherapy 2007; 56: 227–236
   PubMed Web of Science ®Google Scholar
• Crittenden M R, Thanarajasingam U, Vile R G, Gough M J. Intratumoral immunotherapy: using the tumour against itself. Immunology 2005; 114: 11–22
   PubMed Web of Science ®Google Scholar
• Dudley M E, Wunderlich J R, Robbins P F, Yang J C, Hwu P, Schwartzentruber D J, Topalian S L, Sherry R, Restifo N P, Hubicki A M, Robinson M R, Raffeld M, Duray P, Seipp C A, Rogers-Freezer L, Morton K E, Mavroukakis S A, White D E, Rosenberg S A. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002; 298: 850–854
   PubMed Web of Science ®Google Scholar
• Dudley M E, Rosenberg S A. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nature Reviews Cancer 2003; 3: 666–675
   PubMed Web of Science ®Google Scholar
• Dudley M E, Wunderlich J R, Yang J C, Sherry R M, Topalian S L, Restifo N P, Royal R E, Kammula U, White D E, Mavroukakis S A, Rogers L J, Gracia G J, Jones S A, Mangiameli D P, Pelletier M M, Gea-Banacloche J, Robinson M R, Berman D M, Filie A C, Abati A, Rosenberg S A. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. Journal of Clinical Oncology 2005; 23: 2346–2357
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Klebanoff C A, Palmer D C, Wrzesinski C, Kerstann K, Yu Z, Finkelstein S E, Theoret M R, Rosenberg S A, Restifo N P. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. Journal of Clinical Investigation 2005; 115: 1616–1626
   PubMed Web of Science ®Google Scholar
• Harari P M, Huang S M. Modulation of molecular targets to enhance radiation. Clinical Cancer Research 2000; 6: 323–325
   PubMed Web of Science ®Google Scholar
• Imai H, Saio M, Nonaka K, Suwa T, Umemura N, Ouyang G F, Nakagawa J, Tomita H, Osada S, Sugiyama Y, Adachi Y, Takami T. Depletion of CD4(+)CD25(+) regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma. Cancer Science 2007; 98: 416–423
   PubMed Web of Science ®Google Scholar
• Krause M, Hessel F, Wohlfarth J, Zips D, Hoinkis C, Foest H, Petersen C, Short S C, Joiner M C, Baumann M. Ultrafractionation in A7 human malignant glioma in nude mice. International Journal of Radiation Biology 2003; 79: 377–383
   PubMed Web of Science ®Google Scholar
• Krause M, Zips D, Thames H D, Kummermehr J, Baumann M. Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy. Radiotherapy and Oncology 2006; 80: 112–122
   PubMed Web of Science ®Google Scholar
• Kummermehr J, Trott K R. Tumour stem cells. Stem cells, C S Potten. Academic Press Limited, London 1997; 363–400
   Google Scholar
• Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nature Reviews Immunology 2003; 3: 361–370
   PubMed Web of Science ®Google Scholar
• Lohr F, Hu K, Haroon Z, Samulski T V, Huang Q, Beaty J, Dewhirst M W, Li C Y. Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy. Molecular Therapy 2000; 2: 195–203
   PubMed Web of Science ®Google Scholar
• Melief C J, Kast W M. T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunology Reviews 1995; 145: 167–177
   PubMed Web of Science ®Google Scholar
• Milani V, Frankenberger B, Heinz O, Brandl A, Ruhland S, Issels R D, Noessner E. Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response. International Immunology 2005; 17: 257–268
   PubMed Web of Science ®Google Scholar
• Mukherjee P, Ginardi A R, Madsen C S, Sterner C J, Adriance M C, Tevethia M J, Gendler S J. Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred. Journal of Immunology 2000; 165: 3451–3460
   PubMed Web of Science ®Google Scholar
• Newcomb E W, Demaria S, Lukyanov Y, Shao Y, Schnee T, Kawashima N, Lan L, Dewyngaert J K, Zagzag D, McBride W H, Formenti S C. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. Clinical Cancer Research 2006; 12: 4730–4737
   PubMed Web of Science ®Google Scholar
• Radoja S, Saio M, Schaer D, Koneru M, Vukmanovic S, Frey A B. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. Journal of Immunology 2001; 167: 5042–5051
   PubMed Web of Science ®Google Scholar
• Rosenberg S A. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunology Today 1997; 18: 175–182
   PubMedGoogle Scholar
• Ryan M H, Bristol J A, McDuffie E, Abrams S I. Regression of extensive pulmonary metastases in mice by adoptive transfer of antigen-specific CD8(+) CTL reactive against tumor cells expressing a naturally occurring rejection epitope. Journal of Immunology 2001; 167: 4286–4292
   PubMed Web of Science ®Google Scholar
• Sachs L. Angewandte Statistik. Springer, Berlin 1992
   Google Scholar
• Schendel D J, Gansbacher B, Oberneder R, Kriegmair M, Hofstetter A, Riethmuller G, Segurado O G. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. Journal of Immunology 1993; 151: 4209–4220
   PubMed Web of Science ®Google Scholar
• Schuler T, Blankenstein T. Cutting edge: CD8+ effector T cells reject tumors by direct antigen recognition but indirect action on host cells. Journal of Immunology 2003; 170: 4427–4431
   PubMed Web of Science ®Google Scholar
• Smyth M J, Godfrey D I, Trapani J A. A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunology 2001; 2: 293–299
   PubMed Web of Science ®Google Scholar
• Spiotto M T, Rowley D A, Schreiber H. Bystander elimination of antigen loss variants in established tumors. Nature Medicine 2004; 10: 294–298
   PubMed Web of Science ®Google Scholar
• Spiotto M T, Schreiber H. Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells. Cancer Immunity 2005; 5: 8
   PubMedGoogle Scholar
• Vignard V, Lemercier B, Lim A, Pandolfino M C, Guilloux Y, Khammari A, Rabu C, Echasserieau K, Lang F, Gougeon M L, Dreno B, Jotereau F, Labarriere N. Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells. Journal of Immunology 2005; 175: 4797–4805
   PubMed Web of Science ®Google Scholar
• Wahl S M. Transforming growth factor-beta: Innately bipolar. Current Opinion in Immunology 2007; 19: 55–62
   PubMed Web of Science ®Google Scholar
• Whiteside T L. Down-regulation of zeta-chain expression in T cells: A biomarker of prognosis in cancer?. Cancer Immunology and Immunotherapy 2004; 53: 865–878
   PubMed Web of Science ®Google Scholar
• Xue S A, Gao L, Hart D, Gillmore R, Qasim W, Thrasher A, Apperley J, Engels B, Uckert W, Morris E, Stauss H. Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells. Blood 2005; 106: 3062–3067
   PubMed Web of Science ®Google Scholar
• Yaromina A, Zips D, Thames H D, Eicheler W, Krause M, Rosner A, Haase M, Petersen C, Raleigh J A, Quennet V, Walenta S, Mueller-Klieser W, Baumann M. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: The need for a multivariate approach in biomarker studies. Radiotherapy and Oncology 2006; 81: 122–129
   PubMed Web of Science ®Google Scholar
• Yee C, Thompson J A, Byrd D, Riddell S R, Roche P, Celis E, Greenberg P D. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 16168–16173
   PubMed Web of Science ®Google Scholar
• Zhang B, Bowerman N A, Salama J K, Schmidt H, Spiotto M T, Schietinger A, Yu P, Fu Y X, Weichselbaum R R, Rowley D A, Kranz D M, Schreiber H. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. Journal of Experimental Medicine 2007; 204: 49–55
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Mayordomo J I, Tjandrawan T, DeLeo A B, Clarke M R, Lotze M T, Storkus W J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. Journal of Experimental Medicine 1996; 183: 87–97
   PubMed Web of Science ®Google Scholar